Practice question

Answer the question and get instant feedback.

Medium"ADA Standards recommend adding a GLP‑1 RA with proven CV benefit (or an SGLT2 inhibitor) in T2D with ASCVD independent of baseline A1c or metformin use. Sulfonylureas (A)Type 2 DiabetesUSMLEInternal Medicine Boards

A 55-year-year-old with type 2 diabetes, A1c 8.1% on metformin asks about next agent to reduce CV risk. eGFR 58 mL/min/1.73 m². Which class is preferred?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.